R1 RCM Inc

R1 RCM — FY2017 Earnings Presentation

19 slides from R1 RCM's earnings presentation, Mar 9, 2018

  1. Slide 1: Fourth Quarter and Full Year 2017 Results Conference Call

    Fourth Quarter and Full Year 2017 Results Conference Call March 9, 2018 Exhibit 99.2

  2. Slide 2: Forward-Looking Statements and Non-GAAP Financial Measures

    2 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute “forward-looking statements,” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future, not

  3. Slide 3: Q4 and Full Year 2017 Financial Highlights

    3 Q4 and Full Year 2017 Financial Highlights Fourth Quarter Financial Highlights ▪ Revenue of $140.3 million, up $17.1 million sequentially ▪ GAAP net loss of $40.2 million, down $36.6 million sequentially ▪ Adjusted EBITDA of $5.7 million, up $2.6 million sequentially ▪ Includes $0.5 million of leg

  4. Slide 4: 2017 Highlights

    4 2017 Highlights First Quarter ▪ Announced new company brand and vision ▪ Listed on Nasdaq and early-adopted ASC 606 accounting Second Quarter ▪ Expanded Ascension relationship in Wisconsin; added Physician business ▪ Launched Modular Solutions; followed by hiring of chief commercial officer Third

  5. Slide 5: 2018 Announcements Year-to-Date

    5 2018 Announcements Year-to-Date ▪ Intermountain Healthcare ▪ 10-year exclusive operating partner agreement, increases NPR under management by $800M ▪ R1 technology suite fully deployed across 23 hospitals, core platform for RCM workflow, data validation and analytics ▪ Onboarding expected to begin

  6. Slide 6: Technology and Commercial Update

    6 Technology and Commercial Update ▪ Technology ▪ Announced general availability of R1 Patient Experience platform at HIMSS’18 ▪ R1 Automate – expect to have more than 100 RPA programs by year-end ▪ Intermedix to add full suite of physician practice management services and related technology ▪ Comme

  7. Slide 7: 2018 Goals

    7 2018 Goals Growth Goals ▪ Signing of new end-to-end agreement ▪ Launch patient experience platform Operational Goals ▪ High-quality deployment across newly signed business ▪ Expansion of R1 Automate capability Strategic Goals ▪ Close Intermedix acquisition ▪ Leverage Intermedix platform to deliver

  8. Slide 8: 4Q'17 non-GAAP Results – Q/Q and Y/Y Comparison

    8 4Q’17 non-GAAP Results – Q/Q and Y/Y Comparison ($ in millions) 4Q’17 3Q’17 4Q’16 Key change driver(s) Revenue (for 2017); Gross Cash Generated (for 2016) $140.3 $123.2 $69.9 • Q/Q: Onboarding of Wisconsin • Y/Y: Onboarding of Phase 2 and Wisconsin Cost of Services (non-GAAP) $121.9 $106.6 $58.2 •

  9. Slide 9: 2017 vs. 2016 Results (non-GAAP)

    9 2017 vs. 2016 Results (non-GAAP) ($ in millions) 2017 2016 y/y chg. Key change driver(s) Revenue (for 2017); Gross Cash Generated (for 2016) $449.8 $208.7 115.6% • Onboarding of Ascension Phase-1 and Phase-2 Cost of Services (non-GAAP) $397.3 $184.1 115.8% • Onboarding of Ascension employees SG&A

  10. Slide 10: Additional Commentary

    10 Additional Commentary ▪ Cash and equivalents of $166 million as of 12/31/17, incl. restricted cash ▪ Increased $22 million from 9/30/17, driven by: ▪ $5.7 million adjusted EBITDA in Q4 ▪ Positive contribution from working capital ▪ $1.8M Acquisition-related diligence costs in Q4 2017 ▪ Continued

  11. Slide 11: Preliminary 2018 Financial Outlook

    11 Preliminary 2018 Financial Outlook1 ($ in millions) Prior 2018 Outlook (provided 1/8/18) Revenue $675 – $725 GAAP Operating Income $5 – $15 Adjusted EBITDA $40 – $50 NPR growth assumptions – $B New customer $3.0 Total $3.0 Updated 2018 Outlook (provided 2/28/18) $850 – $900 ($30)-($55) $50 – $55

  12. Slide 12: Preliminary 2020 Financial Outlook

    12 Preliminary 2020 Financial Outlook1 ($ in millions) Prior 2020 Outlook (provided 1/8/18) Revenue $800 – $900 GAAP Operating Income $80 – $100 Adjusted EBITDA $120 – $135 Updated 2020 Outlook (provided 2/26/18) $1,200 – $1,300 $115 – $155 $225 – $250 Note: Adjusted EBITDA is a non-GAAP measure, pl

  13. Slide 13: Appendix

    Appendix

  14. Slide 14: Use of Non-GAAP Financial Measures

    14 Use of Non-GAAP Financial Measures ▪ In order to provide a more comprehensive understanding of the information used by R1’s management team in financial and operational decision making, the Company supplements its GAAP consolidated financial statements with certain non-GAAP financial measures, wh

  15. Slide 15: Reconciliation of GAAP net services revenue to non-GAAP Gross Cash Generated

    15 Reconciliation of GAAP net services revenue to non-GAAP Gross Cash Generated from Customer Contracting Activities (for 2016 only) Due to the adoption of Topic 606 as of January 1, 2017, the non-GAAP measure of gross cash generated from customer contracting activities that was utilized by the Comp

  16. Slide 16: Reconciliation of GAAP to non-GAAP Financials

    16 Reconciliation of GAAP to non-GAAP Financials n.m. - not meaningful n.a. - not applicable Due to the adoption of Topic 606 as of January 1, 2017, the non-GAAP measure of gross and net cash generated from customer contracting activities, that was utilized by the Company in 2016, is not applicable

  17. Slide 17: Reconciliation of GAAP to non-GAAP Financials

    17 Reconciliation of GAAP to non-GAAP Financials Reconciliation of GAAP Cash Flow from Operating Activities to Free Cash Flow (for 2H’17) $ in millions $ in millions $ in millions Reconciliation of GAAP Cost of Services to Non-GAAP Cost of Services Reconciliation of GAAP Selling, General and Adminis

  18. Slide 18: Consolidated non-GAAP Financial Information

    18 Consolidated non-GAAP Financial Information $ in millions (1) Excludes share-based compensation, depreciation and amortization and other costs (2) Due to the adoption of Topic 606 as of January 1, 2017, the non-GAAP measure of gross and net cash generated from customer contracting activities that

  19. Slide 19: Reconciliation GAAP Operating Income Guidance to non-GAAP Adjusted EBITDA Guidance

    19 Reconciliation GAAP Operating Income Guidance to non-GAAP Adjusted EBITDA Guidance $ in millions Prior Outlook (provided on 1/08/18) Updated 2018 and 2020 Outlook (provided on 2/26/18) $ in millions 2018 2020 GAAP perating Income Guidance ($30)-($55) $115-$155 Plus: Depreciation and amortization

R1 RCM — FY2017 Earnings Presentation on 6ix